| FVRMX | VSCAX | FVRMX / VSCAX | |
| Total Expense Ratio | 0.91 | 1.10 | 83% |
| Annual Report Gross Expense Ratio | 0.99 | 1.10 | 90% |
| Fund Existence | 20 years | 27 years | - |
| Gain YTD | 5.697 | 7.230 | 79% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 100000 | 1000 | 10,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 217M | 8.84B | 2% |
| Annual Yield % from dividends | 0.62 | 0.25 | 244% |
| Returns for 1 year | -1.05 | 13.42 | -8% |
| Returns for 3 years | -12.40 | 49.33 | -25% |
| Returns for 5 years | -10.38 | 60.33 | -17% |
| Returns for 10 years | -4.05 | 99.03 | -4% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LYFCX | 15.69 | 0.23 | +1.49% |
| AlphaCentric Life Sciences & Hlthcare C | |||
| BEGIX | 17.88 | 0.13 | +0.73% |
| Sterling Capital Equity Income Instl | |||
| TENWX | 14.80 | 0.01 | +0.07% |
| Nuveen Emerging Markets Eq Idx W | |||
| TLORX | 9.00 | N/A | N/A |
| Transamerica Large Value Opps R | |||
| MBGFX | 14.04 | -0.20 | -1.40% |
| MassMutual Blue Chip Growth R4 | |||